These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31433219)

  • 21. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines.
    Sakai K; Maeda S; Saeki K; Nakagawa T; Murakami M; Endo Y; Yonezawa T; Kadosawa T; Mori T; Nishimura R; Matsuki N
    Vet Comp Oncol; 2018 Dec; 16(4):642-649. PubMed ID: 30246405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs.
    Berger EP; Johannes CM; Jergens AE; Allenspach K; Powers BE; Du Y; Mochel JP; Fox LE; Musser ML
    J Vet Intern Med; 2018 Nov; 32(6):2045-2053. PubMed ID: 30307656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder.
    Abbo AH; Jones DR; Masters AR; Stewart JC; Fourez L; Knapp DW
    J Vet Intern Med; 2010; 24(5):1124-30. PubMed ID: 20695986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.
    Knapp DW; Ramos-Vara JA; Moore GE; Dhawan D; Bonney PL; Young KE
    ILAR J; 2014; 55(1):100-18. PubMed ID: 24936033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective evaluation of toceranib phosphate (Palladia) in the treatment of canine carcinomatosis and mesothelioma.
    Hicks KA; Leeper HJ; Curran KM
    Vet Comp Oncol; 2024 Jun; 22(2):245-254. PubMed ID: 38622074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective study of proteinuria in dogs receiving toceranib phosphate.
    Piscoya SL; Hume KR; Balkman CE
    Can Vet J; 2018 Jun; 59(6):611-616. PubMed ID: 29910474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
    Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK
    J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
    J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand.
    Lin TY; Zhang H; Wang S; Xie L; Li B; Rodriguez CO; de Vere White R; Pan CX
    Mol Cancer; 2011 Jan; 10(1):9. PubMed ID: 21272294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
    Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
    J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs.
    Moore AS; Cardona A; Shapiro W; Madewell BR
    J Vet Intern Med; 1990; 4(3):148-52. PubMed ID: 2366224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous metastasis of transitional cell carcinoma in 12 dogs.
    Reed LT; Knapp DW; Miller MA
    Vet Pathol; 2013 Jul; 50(4):676-81. PubMed ID: 23136183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
    Robat C; Burton J; Thamm D; Vail D
    J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer.
    Cronise KE; Hernandez BG; Gustafson DL; Duval DL
    Mol Pharmacol; 2019 Jul; 96(1):36-46. PubMed ID: 31048548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.
    Kim C; Matsuyama A; Mutsaers AJ; Woods JP
    Can Vet J; 2017 Oct; 58(10):1059-1064. PubMed ID: 28966355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.
    Allstadt SD; Rodriguez CO; Boostrom B; Rebhun RB; Skorupski KA
    J Vet Intern Med; 2015 Jan; 29(1):261-7. PubMed ID: 25619518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
    Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
    J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Survival and Glycemic Control with Toceranib Phosphate and Prednisone for a Metastatic Canine Insulinoma.
    Flesner BK; Fletcher JM; Smithee T; Boudreaux B
    J Am Anim Hosp Assoc; 2019; 55(1):e55105. PubMed ID: 30427714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.